Daré Bioscience, Inc.

DARE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$23,075$5,035$10,330$15,698
Short-Term Investments$0$0$0$0
Receivables$369$188$105$230
Inventory$0$0$0$0
Other Curr. Assets$1,560$1,379$1,387$2,520
Total Curr. Assets$25,004$6,602$11,823$18,448
Property Plant & Equip (Net)$4,726$5,307$5,718$2,543
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$300$0
Tax Assets$0$0$0$0
Other NC Assets$1,018$1,070$779$1,111
Total NC Assets$5,744$6,377$6,796$3,653
Other Assets$0$0$0$0
Total Assets$30,749$12,980$18,619$22,101
Liabilities
Payables$1,845$1,763$1,883$1,456
Short-Term Debt$2,479$2,420$2,319$549
Tax Payable$0$0$0$0
Deferred Revenue$1,000$12,327$15,122$16,562
Other Curr. Liab.$15,893$2,712$1,864$3,043
Total Curr. Liab.$21,216$19,221$21,188$21,609
LT Debt$454$613$5,995$754
Deferred Rev, NC$0$1,000$1,000$1,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,221$4,879$0$4,750
Total NC Liab.$6,674$6,492$6,995$6,504
Other Liabilities$0$0$0$0
Cap. Leases$0$3,033$3,573$1,303
Total Liabilities$27,891$25,713$28,183$28,113
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$187,247-$183,684-$179,668-$175,290
AOCI-$396-$403-$416-$429
Other Equity$190,500$171,353$170,519$169,705
Total Equity$2,858-$12,733-$9,564-$6,012
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$30,749$12,980$18,619$22,101
Net Debt-$20,143-$2,002-$2,016-$14,395